Outcomes | Variables in the final model | HR (95% CI) | P* |
---|---|---|---|
OS | Interval (> 30 vs. ≤ 30 days) | 2.44 (1.48–4.01) | < 0.001 |
N category (N2–3 vs. N0–1) | 2.13 (1.44–3.16) | < 0.001 | |
CCI (≥ 1 vs. 0) | 2.21 (1.38–3.54) | 0.001 | |
Age (continuous) | 1.02 (1.00–1.04) | 0.042 | |
lnDNA (continuous) | 1.04 (0.98–1.10) | 0.173 | |
T category (T3–4 vs. T1–2) | 1.42 (0.85–2.36) | 0.183 | |
DFS | Interval (> 30 vs. ≤ 30 days) | 1.99 (1.27–3.11) | 0.003 |
CCI (≥ 1 vs. 0) | 1.87 (1.26–2.79) | 0.002 | |
N category (N2–3 vs. N0–1) | 1.58 (1.14–2.18) | 0.006 | |
lnDNA (continuous) | 1.06 (1.01–1.10) | 0.018 | |
Age (continuous) | 1.01 (1.00–1.03) | 0.126 | |
DMFS | Interval (> 30 vs. ≤ 30 days) | 2.62 (1.54–4.47) | < 0.001 |
N category (N2–3 vs. N0–1) | 3.03 (1.93–4.77) | < 0.001 | |
lnDNA (continuous) | 1.12 (1.04–1.20) | 0.002 | |
CCI (≥ 1 vs. 0) | 1.50 (0.84–2.66) | 0.171 | |
LRFS | Interval (> 30 vs. ≤ 30 days) | 1.53 (0.76–3.08) | 0.238 |
WHO pathology (III vs. I/II) | 0.42 (0.20–0.89) | 0.023 | |
N category (N2–3 vs. N0–1) | 0.63 (0.37–1.07) | 0.086 | |
lnDNA (continuous) | 1.06 (0.99–1.13) | 0.099 |